Gladstone in the News
September 3, 2020
STAT—Senior Investigators Todd McDevitt, PhD, and Bruce Conklin, MD, comment on their recent findings of severe damage in cardiac cells exposed to SARS-CoV-2 in the lab and in the heart cells of deceased COVID-19 patients. They also explain why they felt the need to share these findings rapidly with the scientific community via the preprint publishing platform bioRxiv.
Gladstone Experts
COVID-19
Cardiovascular Disease
Data Science and Biotechnology
Conklin Lab
McDevitt Lab
Gladstone in the News
August 25, 2020
Innovative Genomics Institute—In a biographical interview, Gladstone Investigator Bruce Conklin describes how he was inspired to pursue basic research by a patient he encountered in medical school, and shares his love of history and animal watching.
Gladstone Experts
Conklin Lab
Gladstone in the News
May 3, 2020
Science Cover—In addition to causing respiratory disease, COVID-19 can also affect the cardiovascular system, and indeed heart failure may be the cause of many COVID-19 deaths. At Gladstone, Senior Investigators Bruce Conklin and Todd McDevitt are using stem cell–derived heart cells and microtissues to investigate how COVID-19 affects heart cardiac function, and to identify new therapeutic targets.
Gladstone Experts
COVID-19
Cardiovascular Disease
iPS Cell Research Center
Conklin Lab
McDevitt Lab
Gladstone in the News
February 1, 2020
CMTA—Gladstone Senior Investigator Bruce Conklin and Luke Judge from UC San Francisco recently received a grant from the Charcot-Marie-Tooth Association to develop the gene-editing technique known as CRISPR for application to CMT2A, 2E, and 2F.
Gladstone Experts
Conklin Lab
